Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases

Recruiting now · Not applicable

Conditions studied: Prehabilitation, Neoadjuvant Therapy, Liver Metastases

In brief

Liver resection is the only curative treatment for patients with colorectal liver metastases (CRLM). Most patients undergo chemotherapy (CT) before liver surgery. CT objectively decreases patient functional capacity. It has already been demonstrated that a structured training program carried out during the 4 weeks following CT, while the patient is waiting for liver resection, is able to return the functional capacity to baseline levels. Despite this, multimodal prehabilitation programs (MPP) during preoperative CT have not been evaluated or implemented. The aim of this study is to investigate whether a 16-week MPP applied during and following CT in CRLM patients will result in a significant increase in physical fitness when compared to those that undergo MPP only during the 4-weeks, between the end of CT and liver resection.

Key facts

Study ID

NCT04520737

Run by

Institut Investigacio Sanitaria Pere Virgili

People needed

84

Starts

2021-02-01

Expected to finish

2026-12-31

Last updated by the study team

2024-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Written informed consent obtained from subject to participate in the study.

You may not qualify if…

• Age <18 years
• ASA health class status IV-V
• Mental conditions or disabling orthopedic and neuromuscular disease that prevent physical exercise or may compromise adherence to the program
• Medical contraindication to perform exercise
• Inability to obtain informed consent

Where it is running

• Hospital Universitari de Tarragona Joan XXIII — Tarragona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.